• Lypressin Acetate: Applied Protocols for Vasopressor and Ant

  2026-07-02

  Lypressin acetate stands at the intersection of classic antidiuretic studies and emerging antiviral research, offering unmatched precision and reproducibility for GPCR-driven workflows. This guide translates recent structural and pharmacodynamic insights into actionable protocols and troubleshooting strategies for fluid homeostasis, vasoconstriction, and SARS-CoV-2 RdRp inhibition studies.

• GSK J4 HCl: Epigenetic Precision for Immune and Inflammatory

  2026-07-02

  Explore how GSK J4 HCl, a potent JMJD3 inhibitor, is uniquely positioned for advanced epigenetic regulation research. This deep-dive reveals insights into immune modulation, practical assay nuances, and emerging therapeutic frontiers.

• FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone): P

  2026-07-01

  Unlock the full analytical power of FCCP as a mitochondrial uncoupler for metabolic regulation and hypoxia pathway research. This guide translates new mechanistic insights into actionable workflows, troubleshooting strategies, and comparative advantages for advanced cell biology experiments.

• Dual Glutamate Receptor Blockade Mitigates Soman Neurotoxici

  2026-07-01

  This study demonstrates that dual inhibition of AMPA and NMDA receptors with IEM-1925 provides robust antiseizure, neuroprotective, and cognitive benefits in a rat model of soman-induced status epilepticus. The findings clarify the mechanistic value of targeting glutamatergic signaling to counteract organophosphorus nerve agent–induced brain injury and suggest key parameters for translational neuroprotection assays.

• Intraarticular RTX for Osteoarthritis Pain: Mechanistic Adva

  2026-06-30

  The reference review synthesizes preclinical and early clinical evidence on intraarticular resiniferatoxin (RTX) as a novel approach for osteoarthritic pain. By targeting TRPV1-positive sensory neurons, RTX offers long-lasting analgesia through chemical inactivation at the pain source, potentially enabling tissue remodeling and minimizing systemic side effects.

• 3D Organoid-Fibroblast Co-Cultures Model Chemoresistance in

  2026-06-30

  Schuth et al. introduce a three-dimensional co-culture system pairing patient-derived pancreatic cancer organoids with matched cancer-associated fibroblasts (CAFs), enabling mechanistic study of stroma-mediated chemoresistance. Their approach provides deeper insights into tumor–stroma interactions, with implications for refining drug screening and understanding resistance pathways in pancreatic ductal adenocarcinoma.

• DiscoveryProbe Protease Inhibitor Library: Mechanistic Insig

  2026-06-29

  Explore the DiscoveryProbe Protease Inhibitor Library's unique value for protease inhibition in advanced cancer research. This article delves into mechanistic insights, assay protocols, and implications from recent breakthroughs.

• Flubendazole in Functional Cancer Assays: Beyond Autophagy A

  2026-06-29

  Explore how Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) enables advanced, multidimensional in vitro assessment of drug responses in cancer biology research. This article uniquely bridges autophagy modulation and functional viability metrics, revealing new strategies for robust experimental design.

• Platycodin D Targets RFC4 and Notch Axis in NSCLC Apoptosis

  2026-06-28

  By integrating multidimensional proteomics and functional assays, the study identifies RFC4 as a key molecular target of Platycodin D in non-small cell lung cancer. The work uncovers how PD-mediated RFC4 binding suppresses Notch signaling, triggering apoptosis, and highlights the value of advanced proteomics in elucidating drug mechanisms.

• LDH Cytotoxicity Assay Kit: Advanced Cell Damage Quantificat

  2026-06-27

  The LDH Cytotoxicity Assay Kit enables sensitive, non-radioactive cell cytotoxicity measurement with robust compatibility for nanomaterial research and disease modeling. This article demystifies protocol refinements, cross-validates with nanocomposite studies, and delivers troubleshooting strategies to maximize data integrity.

• Cy7 NHS Ester: Practical Guidance for Near-Infrared Protein

  2026-06-26

  Cy7 NHS ester is a sulfonated, highly water-soluble near-infrared dye optimized for labeling proteins and peptides at amino groups, particularly when working with sensitive biomolecules. Its hydrophilicity and minimal fluorescence quenching support robust, non-destructive imaging in live systems. It is not recommended for workflows requiring long-term storage of dye solutions or labeling of biomolecules lacking accessible amino groups.

• EdU Imaging Kits (Cy3): Precision S-Phase Detection Workflow

  2026-06-26

  EdU Imaging Kits (Cy3) enable high-sensitivity, denaturation-free detection of cell proliferation, streamlining advanced workflows in oncology and genotoxicity testing. This guide offers actionable setup, protocol, and troubleshooting strategies, harnessing reference evidence and best practices for reproducible results.

• Lypressin Acetate in Applied Vasopressor and Antiviral Resea

  2026-06-25

  Lypressin acetate stands out as a robust vasopressin analog, enabling reproducible antidiuretic, vasopressor, and emerging antiviral assays. This article dissects experimental workflows, troubleshooting tips, and protocol optimizations that maximize data fidelity and translational relevance using APExBIO’s Lypressin acetate.

• Biotin-tyramide: Precision Signal Amplification in IHC & ISH

  2026-06-25

  Biotin-tyramide enables ultra-sensitive, spatially resolved detection in immunohistochemistry and in situ hybridization. Leveraging HRP-catalyzed deposition, it empowers next-generation workflows in biological imaging and RNA proximity labeling with unmatched signal amplification and specificity.

• Etoposide (VP-16): Reliable Solutions for DNA Damage Assays

  2026-06-24

  This article offers scenario-driven, evidence-based guidance for biomedical researchers using Etoposide (VP-16) (SKU A1971) in DNA damage, apoptosis, and cytotoxicity assays. It addresses real laboratory challenges, providing data-backed recommendations and protocol insights to maximize reproducibility and assay sensitivity with Etoposide (VP-16).

11351 records 1/757 page Next 12345 下5页 Last page